Submission Details
| 510(k) Number | K150921 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 06, 2015 |
| Decision Date | April 12, 2016 |
| Days to Decision | 372 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
K150921 is an FDA 510(k) clearance for the Orbit Infusion Set, a Set, Administration, Intravascular (Class II — Special Controls, product code FPA), submitted by Ypsomed AG (Burgdorf, CH). The FDA issued a Cleared decision on April 12, 2016, 372 days after receiving the submission on April 6, 2015. This device falls under the General Hospital review panel. Regulated under 21 CFR 880.5440.
| 510(k) Number | K150921 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 06, 2015 |
| Decision Date | April 12, 2016 |
| Days to Decision | 372 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
| Product Code | FPA — Set, Administration, Intravascular |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 880.5440 |